Bernard Kaić
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bernard Kaić has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Tatjana Vilibic-Cavlek
WHO National Measles/Rubella Laboratory, Department of Virology, Croatian Institute of Public Health, 10000 Zagreb, Croatia
9 shared publications - Ira Gjenero-Margan
Department of Epidemiology, University of Applied Health Studies, Zagreb, Croatia
5 shared publications I Gjenero-Margan
Croatian Institute of Public Health, Department of Infectious Disease Epidemiology, Zagreb, Croatia
3 shared publications- Irena Tabain
Croatian Institute of Public Health, Zagreb, Croatia
3 shared publications Iva Pem-Novosel
Department of Epidemiology, Croatian National Institute of Public Health, Zagreb, Croatia
3 shared publications- Alan Medić
Department of Epidemiology, Zadar County Institute of Public Health, Zadar, Croatia
2 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by MDPI AG in Antibodies
- Vol. 15 (6) , 103
Rubella Antibody Prevalence Among Women of Reproductive Age in Croatia: Implications for the Prevention of Congenital Rubella Syndrome
Background/Objectives: Rubella immunity in childbearing-aged women is crucial due to the risk of congenital rubella syndrome (CRS). This study analyzed temporal trends in rubella virus (RUBV) seroprevalence among women of reproductive age in Croatia. Methods: The study included 1490 childbearing-aged and pregnant women aged 16–45 years tested between January 2015 and December 2024. RUBV IgM and IgG antibodies were detected using a commercial ELISA, with IgM-positive samples further assessed for IgG avidity. Results: RUBV IgG antibodies were detected in 1407/1490 (94.4%) of participants, with significant differences between years ranging from 87.4% (2019) to 96.4% (2023). High seropositivity was observed across all age groups, with no significant differences (93.1–95.1%). The area of residence was not associated with seroprevalence (continental Croatia: 94.8%, coastal Croatia: 93.8%). Similarly, no significant differences in seropositivity were observed according to settlement type (urban regions: 94.1%, suburban/rural regions: 95.1%). The year of sampling was the only predictor that showed significance in the multivariate regression model. A statistically significant effect of calendar year was demonstrated, indicating that the odds of IgG seropositivity increased by approximately 8% per year. Conclusions: This study demonstrated consistently high RUBV seroprevalence among Croatian women of reproductive age across all age groups during the past decade. Maintaining this high level of immunity is crucial for the prevention of CRS.
- 3 November 2026
- Published by MDPI AG in Antibodies
- Vol. 15 (6) , 103
Open AccessRubella Antibody Prevalence Among Women of Reproductive Age in Croatia: Implications for the Prevention of Congenital Rubella Syndrome
Background/Objectives: Rubella immunity in childbearing-aged women is crucial due to the risk of congenital rubella syndrome (CRS). This study analyzed temporal trends in rubella virus (RUBV) seroprevalence among women of reproductive age in Croatia. Methods: The study included 1490 childbearing-aged and pregnant women aged 16–45 years tested between January 2015 and December 2024. RUBV IgM and IgG antibodies were detected using a commercial ELISA, with IgM-positive samples further assessed for IgG avidity. Results: RUBV IgG antibodies were detected in 1407/1490 (94.4%) of participants, with significant differences between years ranging from 87.4% (2019) to 96.4% (2023). High seropositivity was observed across all age groups, with no significant differences (93.1–95.1%). The area of residence was not associated with seroprevalence (continental Croatia: 94.8%, coastal Croatia: 93.8%). Similarly, no significant differences in seropositivity were observed according to settlement type (urban regions: 94.1%, suburban/rural regions: 95.1%). The year of sampling was the only predictor that showed significance in the multivariate regression model. A statistically significant effect of calendar year was demonstrated, indicating that the odds of IgG seropositivity increased by approximately 8% per year. Conclusions: This study demonstrated consistently high RUBV seroprevalence among Croatian women of reproductive age across all age groups during the past decade. Maintaining this high level of immunity is crucial for the prevention of CRS.
- Open Access
Assessment of Measles Immunity in the Croatian Population: A Retrospective Seroprevalence Study, 2015–2025
Background/Objectives: Measles is a highly contagious infectious disease. Maintaining a high level of measles immunity in the population is essential due to the extremely high transmissibility of the measles virus (MV). We analyzed the MV seroprevalence in the Croatian population. Methods: A total of 1998 individuals tested consecutively for MV antibodies from 2015 to 2025 inclusive were included. MV IgG antibodies were detected using a commercial ELISA. Results: The overall seroprevalence rate was 75.1%, with significant yearly differences, ranging from 50.0 to 86.5%, and a declining trend since 2023. No differences were observed between sexes (males 71.6%, females 71.9%). The seroprevalence increased with age, from 60.9% in the 1–10 age group to 91.1% in the 61+ age group. Significant geographic differences were found, with higher seropositivity rates in coastal regions compared to continental regions (81.3 and 71.0%, respectively). Settlement type (urban, suburban/rural) was not associated with the MV seroprevalence. The results of the multivariable logistic regression analysis showed that year, age, and region were significantly associated with IgG seropositivity. Each additional calendar year was associated with lower odds of IgG positivity (OR = 0.82), while each additional year of age was associated with higher odds (OR = 1.04). Region was also a significant predictor (OR = 1.65), while settlement was not significantly associated with seropositivity after adjustment for other variables. Conclusions: Croatia has historically maintained high measles coverage, but lower uptake in some regions and age groups may be creating immunity gaps. The lower post-2022 seropositivity underscores significant immunity gaps, particularly among highly susceptible groups that were exposed to outbreaks and tested during that period.
Open AccessAssessment of Measles Immunity in the Croatian Population: A Retrospective Seroprevalence Study, 2015–2025
Background/Objectives: Measles is a highly contagious infectious disease. Maintaining a high level of measles immunity in the population is essential due to the extremely high transmissibility of the measles virus (MV). We analyzed the MV seroprevalence in the Croatian population. Methods: A total of 1998 individuals tested consecutively for MV antibodies from 2015 to 2025 inclusive were included. MV IgG antibodies were detected using a commercial ELISA. Results: The overall seroprevalence rate was 75.1%, with significant yearly differences, ranging from 50.0 to 86.5%, and a declining trend since 2023. No differences were observed between sexes (males 71.6%, females 71.9%). The seroprevalence increased with age, from 60.9% in the 1–10 age group to 91.1% in the 61+ age group. Significant geographic differences were found, with higher seropositivity rates in coastal regions compared to continental regions (81.3 and 71.0%, respectively). Settlement type (urban, suburban/rural) was not associated with the MV seroprevalence. The results of the multivariable logistic regression analysis showed that year, age, and region were significantly associated with IgG seropositivity. Each additional calendar year was associated with lower odds of IgG positivity (OR = 0.82), while each additional year of age was associated with higher odds (OR = 1.04). Region was also a significant predictor (OR = 1.65), while settlement was not significantly associated with seropositivity after adjustment for other variables. Conclusions: Croatia has historically maintained high measles coverage, but lower uptake in some regions and age groups may be creating immunity gaps. The lower post-2022 seropositivity underscores significant immunity gaps, particularly among highly susceptible groups that were exposed to outbreaks and tested during that period.
- Open Access
Emerging Trends in the Epidemiology of COVID-19: The Croatian ‘One Health’ Perspective
During the four pandemic waves, a total of 560,504 cases and 10,178 deaths due to COVID-19 were reported in Croatia. The Alpha variant, dominant from March 2021 (>50% of positive samples), was rapidly replaced by Delta variants (>90%) by August 2021. Several seroprevalence studies were conducted in different populations (general population, children/adolescents, professional athletes, healthcare workers, veterinarians) and in immunocompromised patients (hemodialysis patients, liver/kidney transplant recipients). After the first pandemic wave, seroprevalence rates of neutralizing (NT) antibodies were reported to be 0.2–5.5%. Significantly higher seropositivity was detected during/after the second wave, 2.6–18.7%. Two studies conducted in pet animals (February-June 2020/July–December 2020) reported SARS-CoV-2 NT antibodies in 0.76% of cats and 0.31–14.69% of dogs, respectively. SARS-CoV-2 NT antibodies were not detected in wildlife. Environmental samples taken in the households of COVID-19 patients showed high-touch personal objects as most frequently contaminated (17.3%), followed by surfaces in patients’ rooms (14.6%), kitchens (13.3%) and bathrooms (8.3%). SARS-CoV-2 RNA was also detected in 96.8% affluent water samples, while all effluent water samples tested negative. Detection of SARS-CoV-2 in humans, animals and the environment suggests that the ‘One Health’ approach is critical to controlling COVID-19 and future pandemics.
Open AccessEmerging Trends in the Epidemiology of COVID-19: The Croatian ‘One Health’ Perspective
During the four pandemic waves, a total of 560,504 cases and 10,178 deaths due to COVID-19 were reported in Croatia. The Alpha variant, dominant from March 2021 (>50% of positive samples), was rapidly replaced by Delta variants (>90%) by August 2021. Several seroprevalence studies were conducted in different populations (general population, children/adolescents, professional athletes, healthcare workers, veterinarians) and in immunocompromised patients (hemodialysis patients, liver/kidney transplant recipients). After the first pandemic wave, seroprevalence rates of neutralizing (NT) antibodies were reported to be 0.2–5.5%. Significantly higher seropositivity was detected during/after the second wave, 2.6–18.7%. Two studies conducted in pet animals (February-June 2020/July–December 2020) reported SARS-CoV-2 NT antibodies in 0.76% of cats and 0.31–14.69% of dogs, respectively. SARS-CoV-2 NT antibodies were not detected in wildlife. Environmental samples taken in the households of COVID-19 patients showed high-touch personal objects as most frequently contaminated (17.3%), followed by surfaces in patients’ rooms (14.6%), kitchens (13.3%) and bathrooms (8.3%). SARS-CoV-2 RNA was also detected in 96.8% affluent water samples, while all effluent water samples tested negative. Detection of SARS-CoV-2 in humans, animals and the environment suggests that the ‘One Health’ approach is critical to controlling COVID-19 and future pandemics.
- Open Access
SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with a pandemic spread. So far, a total of 349,910 SARS-CoV-2 cases and 7687 deaths were reported in Croatia. We analyzed the seroprevalence and neutralizing (NT) antibody response in the Croatian general population after the first (May–July 2020) and second (December 2020–February 2021) pandemic wave. Initial serological testing was performed using a commercial ELISA, with confirmation of reactive samples by a virus neutralization test (VNT). A significant difference in the overall seroprevalence rate was found after the first (ELISA 2.2%, VNT 0.2%) and second waves (ELISA 25.1%, VNT 18.7%). Seropositive individuals were detected in all age groups, with significant differences according to age. The lowest prevalence of NT antibodies was documented in the youngest (p < 0.001) was observed. SARS-CoV-2 NT antibody titers seem to be age-related, with the highest NT activity in children under 10 years and individuals above 50 years.
Open AccessSARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with a pandemic spread. So far, a total of 349,910 SARS-CoV-2 cases and 7687 deaths were reported in Croatia. We analyzed the seroprevalence and neutralizing (NT) antibody response in the Croatian general population after the first (May–July 2020) and second (December 2020–February 2021) pandemic wave. Initial serological testing was performed using a commercial ELISA, with confirmation of reactive samples by a virus neutralization test (VNT). A significant difference in the overall seroprevalence rate was found after the first (ELISA 2.2%, VNT 0.2%) and second waves (ELISA 25.1%, VNT 18.7%). Seropositive individuals were detected in all age groups, with significant differences according to age. The lowest prevalence of NT antibodies was documented in the youngest (p < 0.001) was observed. SARS-CoV-2 NT antibody titers seem to be age-related, with the highest NT activity in children under 10 years and individuals above 50 years.
- Open Access
- 1 October 2019
- Published by Croatian Medical Journals in Croatian Medical Journal
- Vol. 60 (5) , 393-396
Measles outbreak: a warning sign of troubles ahead
- 1 October 2019
- Published by Croatian Medical Journals in Croatian Medical Journal
- Vol. 60 (5) , 393-396
Open AccessMeasles outbreak: a warning sign of troubles ahead
- Open Access
- 30 June 2018
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 12 (06) , 499-503
Imported brucellosis and Q-fever coinfection in Croatia: a case report
The brucellosis and Q-fever coinfection is very rarely reported. To our knowledge, this is the first case report of concomitant brucellosis and Q-fever, most likely imported in Croatia. A 30-year-old male agricultural worker was hospitalized on 22 April 2017 after a ten days fever up to 40°C with chills, shivering, excessive sweating, general weakness, loss of appetite and headache. A month and a half prior to the hospitalization he lost 18 kg of body weight. Three weeks before hospitalization the patient returned from Kupres (Bosnia and Herzegovina) where he was working for the past year on a sheep farm and consumed unpasteurized dairy products of sheep origin. At admission, his condition was moderately severe due to pronounced dehydration. Routine laboratory tests showed slightly elevated erythrocyte sedimentation rate, anemia, thrombocytopenia and elevated liver transaminases. The chest X-ray showed an inhomogeneous infiltrate of the lower right lung. Three sets of blood culture were cultivated. After 48 hours incubation, bacterial growth was detected in aerobic bottles. Gram-stained smear revealed small, gram-negative coccobacilli. Specimens were subcultured on blood and chocolate agar plates. Using a Vitek GN identification card, the isolated organism was identified as Brucella melitensis. 16S rRNA gene sequencing of the isolate confirmed it as a Brucella sp. Rose-Bengal test was positive, while Wright agglutination test showed a significant increase in antibody titer from 80 to 640 in paired sera. Using indirect immunofluorescence assay (IFA), Coxiella burnetii phase II IgM/IgG titers were 50 and 1024, respectively indicating acute Q-fever. The patient was treated with doxycycline and rifampicin. So far, there has been no relapse or signs of chronic infection.
- 30 June 2018
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 12 (06) , 499-503
Open AccessImported brucellosis and Q-fever coinfection in Croatia: a case report
The brucellosis and Q-fever coinfection is very rarely reported. To our knowledge, this is the first case report of concomitant brucellosis and Q-fever, most likely imported in Croatia. A 30-year-old male agricultural worker was hospitalized on 22 April 2017 after a ten days fever up to 40°C with chills, shivering, excessive sweating, general weakness, loss of appetite and headache. A month and a half prior to the hospitalization he lost 18 kg of body weight. Three weeks before hospitalization the patient returned from Kupres (Bosnia and Herzegovina) where he was working for the past year on a sheep farm and consumed unpasteurized dairy products of sheep origin. At admission, his condition was moderately severe due to pronounced dehydration. Routine laboratory tests showed slightly elevated erythrocyte sedimentation rate, anemia, thrombocytopenia and elevated liver transaminases. The chest X-ray showed an inhomogeneous infiltrate of the lower right lung. Three sets of blood culture were cultivated. After 48 hours incubation, bacterial growth was detected in aerobic bottles. Gram-stained smear revealed small, gram-negative coccobacilli. Specimens were subcultured on blood and chocolate agar plates. Using a Vitek GN identification card, the isolated organism was identified as Brucella melitensis. 16S rRNA gene sequencing of the isolate confirmed it as a Brucella sp. Rose-Bengal test was positive, while Wright agglutination test showed a significant increase in antibody titer from 80 to 640 in paired sera. Using indirect immunofluorescence assay (IFA), Coxiella burnetii phase II IgM/IgG titers were 50 and 1024, respectively indicating acute Q-fever. The patient was treated with doxycycline and rifampicin. So far, there has been no relapse or signs of chronic infection.
- 1 June 2015
- Published by Akademiai Kiado Zrt. in Acta Microbiologica Et Immunologica Hungarica
- Vol. 62 (2) , 199-206
Seroprevalence and entomological study on Chikungunya virus at the Croatian littoral
During 2011–2012, a total of 1008 serum samples from randomly selected inhabitants of seven Croatian counties located on the Adriatic Coast were tested for the presence of chikungunya virus (CHIKV) IgG antibodies using indirect immunofluorescence assay. Nine participants (0.9%) from four counties were found to be seropositive to CHIKV. Seroprevalence varied from 0.5% to 1.8% between counties. Additionally, a total of 3,699 mosquitoes were captured in 126 localities from August 16 to September 24, 2011. Three mosquito species were found: Ae. albopictus (3010/81.4%), Cx. pipiens (688/18.6%) and only one specimen of the Cs. longiareolata. Female mosquitoes (N = 1,748) were pooled. All pools tested negative for CHIKV RNA using a real-time RT-PCR.
- 1 June 2015
- Published by Akademiai Kiado Zrt. in Acta Microbiologica Et Immunologica Hungarica
- Vol. 62 (2) , 199-206
Seroprevalence and entomological study on Chikungunya virus at the Croatian littoral
During 2011–2012, a total of 1008 serum samples from randomly selected inhabitants of seven Croatian counties located on the Adriatic Coast were tested for the presence of chikungunya virus (CHIKV) IgG antibodies using indirect immunofluorescence assay. Nine participants (0.9%) from four counties were found to be seropositive to CHIKV. Seroprevalence varied from 0.5% to 1.8% between counties. Additionally, a total of 3,699 mosquitoes were captured in 126 localities from August 16 to September 24, 2011. Three mosquito species were found: Ae. albopictus (3010/81.4%), Cx. pipiens (688/18.6%) and only one specimen of the Cs. longiareolata. Female mosquitoes (N = 1,748) were pooled. All pools tested negative for CHIKV RNA using a real-time RT-PCR.
- Open Access
- 8 January 2015
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 143 (12) , 2596-2603
Influenza vaccine effectiveness estimates in Croatia in 2010–2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus
SUMMARY: This is a retrospective study using the test-negative case-control method to estimate seasonal 2010–2011 influenza vaccine effectiveness (VE) in Croatia. Of patients consulting a physician for influenza-like illness (ILI) and for whom a swab was taken, we compared RT–PCR influenza-positive and RT–PCR influenza-negative patients. We used a structured questionnaire and physicians' records to obtain information on vaccination status and potential confounders. We conducted a complete case analysis using logistic regression to measure adjusted VE overall, against A(H1N1)pdm09 and in age groups. Out of 785 interviewed patients, 495 eligible patients were included in the study, after applying exclusion criteria [217 cases, of which 92·6% were A(H1N1)pdm09 positive, 278 controls]. Crude VE was 31·9% [95% confidence interval (CI) −40·9 to 67·1] and adjusted VE was 20·7% (95% CI −71·4 to 63·3), with higher VE in youngest and oldest age groups. Results from this first VE study in Croatia suggest a low to moderate VE for the 2010–2011 season. Studies year on year are needed with a greater sample size to provide more precise estimates, and also by age group and risk groups for vaccination.
- 8 January 2015
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 143 (12) , 2596-2603
Open AccessInfluenza vaccine effectiveness estimates in Croatia in 2010–2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus
SUMMARY: This is a retrospective study using the test-negative case-control method to estimate seasonal 2010–2011 influenza vaccine effectiveness (VE) in Croatia. Of patients consulting a physician for influenza-like illness (ILI) and for whom a swab was taken, we compared RT–PCR influenza-positive and RT–PCR influenza-negative patients. We used a structured questionnaire and physicians' records to obtain information on vaccination status and potential confounders. We conducted a complete case analysis using logistic regression to measure adjusted VE overall, against A(H1N1)pdm09 and in age groups. Out of 785 interviewed patients, 495 eligible patients were included in the study, after applying exclusion criteria [217 cases, of which 92·6% were A(H1N1)pdm09 positive, 278 controls]. Crude VE was 31·9% [95% confidence interval (CI) −40·9 to 67·1] and adjusted VE was 20·7% (95% CI −71·4 to 63·3), with higher VE in youngest and oldest age groups. Results from this first VE study in Croatia suggest a low to moderate VE for the 2010–2011 season. Studies year on year are needed with a greater sample size to provide more precise estimates, and also by age group and risk groups for vaccination.
- 1 January 2015
- Vol. 38 (1) , 97-100
Dengue virus infection in Croatia: seroprevalence and entomological study.
During 2011-2012, a total of 1,180 sera samples were collected from residents of seven Croatian counties located on the Adriatic Coast and four counties in northeastern Croatia and tested for the presence of dengue virus (DENV) IgG antibodies using ELISA. Reactive samples were further tested by IFA. Seven samples (0.59%) tested positive for DENV antibodies. Seroprevalence rates by county varied from 0-2.21%. The highest seropositivity rate (2.21%) was found in the Dubrovnik-Neretva County where autochthonous dengue cases were recorded in 2010. Additionally,3,699 mosquitoes were collected from 126 localities along the Adriatic coast in August-September, 2011. Aedes albopictus was the most prevalent species (81.37%). No evidence of DENV RNA was detected by RT-PCR among 1,748 female mosquitoes.
- 1 January 2015
- Vol. 38 (1) , 97-100
Dengue virus infection in Croatia: seroprevalence and entomological study.
During 2011-2012, a total of 1,180 sera samples were collected from residents of seven Croatian counties located on the Adriatic Coast and four counties in northeastern Croatia and tested for the presence of dengue virus (DENV) IgG antibodies using ELISA. Reactive samples were further tested by IFA. Seven samples (0.59%) tested positive for DENV antibodies. Seroprevalence rates by county varied from 0-2.21%. The highest seropositivity rate (2.21%) was found in the Dubrovnik-Neretva County where autochthonous dengue cases were recorded in 2010. Additionally,3,699 mosquitoes were collected from 126 localities along the Adriatic coast in August-September, 2011. Aedes albopictus was the most prevalent species (81.37%). No evidence of DENV RNA was detected by RT-PCR among 1,748 female mosquitoes.
- 1 October 2013
- Vol. 67 (4) , 273-9
[Epidemiology of viral hepatitis].
Understanding the country-specific epidemiology of disease, which may vary greatly among countries, is crucial for identifying the most appropriate preventive and control measures. An overview of the local epidemiology of viral hepatitis in Croatia is given in this paper. The overall prevalence of hepatitis B in Croatia is low (less than 2% HBsAg carriers in the general population). Hepatitis B incidence and prevalence began to decline significantly following the introduction of universal hepatitis B vaccination in 1999. Information on HBsAg seroprevalence is derived from routine testing of certain subpopulations (pregnant women, blood donors) and seroprevalence studies mostly targeted at high-risk populations. Universal childhood vaccination against hepatitis B remains the main preventive measure. We recommend testing for immunity one to two months after the third dose of hepatitis B vaccine for health-care workers. The incidence and prevalence of hepatitis C have also been declining in the general population. The main preventive measures are ensuring safety of blood products, prevention of drug abuse, and harm reduction programs for intravenous drug users. Hepatitis A incidence has declined dramatically since fifty years ago, when thousands of cases were reported annually. In the last five years, an average of twenty cases have been reported per year. The reduction of hepatitis A is a consequence of improved personal and community hygiene and sanitation. Hepatitis D has not been reported in Croatia. The risk of hepatitis D will get to be even smaller as the proportion of population vaccinated against hepatitis B builds up. Hepatitis E is reported only sporadically in Croatia, mostly in persons occupationally in contact with pigs and in travelers to endemic countries. In conclusion, Croatia is a low prevalence country for hepatitides A, B and C. Hepatitis D has not been reported to occur in Croatia and there are only sporadic cases of hepatitis E. Since hepatitis A is a rare disease occurring sporadically, which is a consequence of improved sanitation and hygiene, hepatitides B and C are the main causes of viral hepatitis in Croatia. The introduction of universal mandatory hepatitis B vaccination of schoolchildren in 1999 resulted in a decrease in the incidence of hepatitis B, which is most pronounced in adolescents and young adults, and further decrease in the incidence and prevalence is expected as the pool of susceptible individuals decreases through vaccination. The incidence of hepatitis C is decreasing as well. In spite of a relatively favorable epidemiological situation, hepatitis B and C are still a significant public health burden with an estimated 25,000 persons chronically infected with HBV and about 40,000 persons chronically infected with HCV in Croatia.
- 1 October 2013
- Vol. 67 (4) , 273-9
[Epidemiology of viral hepatitis].
Understanding the country-specific epidemiology of disease, which may vary greatly among countries, is crucial for identifying the most appropriate preventive and control measures. An overview of the local epidemiology of viral hepatitis in Croatia is given in this paper. The overall prevalence of hepatitis B in Croatia is low (less than 2% HBsAg carriers in the general population). Hepatitis B incidence and prevalence began to decline significantly following the introduction of universal hepatitis B vaccination in 1999. Information on HBsAg seroprevalence is derived from routine testing of certain subpopulations (pregnant women, blood donors) and seroprevalence studies mostly targeted at high-risk populations. Universal childhood vaccination against hepatitis B remains the main preventive measure. We recommend testing for immunity one to two months after the third dose of hepatitis B vaccine for health-care workers. The incidence and prevalence of hepatitis C have also been declining in the general population. The main preventive measures are ensuring safety of blood products, prevention of drug abuse, and harm reduction programs for intravenous drug users. Hepatitis A incidence has declined dramatically since fifty years ago, when thousands of cases were reported annually. In the last five years, an average of twenty cases have been reported per year. The reduction of hepatitis A is a consequence of improved personal and community hygiene and sanitation. Hepatitis D has not been reported in Croatia. The risk of hepatitis D will get to be even smaller as the proportion of population vaccinated against hepatitis B builds up. Hepatitis E is reported only sporadically in Croatia, mostly in persons occupationally in contact with pigs and in travelers to endemic countries. In conclusion, Croatia is a low prevalence country for hepatitides A, B and C. Hepatitis D has not been reported to occur in Croatia and there are only sporadic cases of hepatitis E. Since hepatitis A is a rare disease occurring sporadically, which is a consequence of improved sanitation and hygiene, hepatitides B and C are the main causes of viral hepatitis in Croatia. The introduction of universal mandatory hepatitis B vaccination of schoolchildren in 1999 resulted in a decrease in the incidence of hepatitis B, which is most pronounced in adolescents and young adults, and further decrease in the incidence and prevalence is expected as the pool of susceptible individuals decreases through vaccination. The incidence of hepatitis C is decreasing as well. In spite of a relatively favorable epidemiological situation, hepatitis B and C are still a significant public health burden with an estimated 25,000 persons chronically infected with HBV and about 40,000 persons chronically infected with HCV in Croatia.